Top insider buys: May 30 – Jun 5, 2022

The largest open-market purchases company insiders reported on SEC Form 4 between May 30 – Jun 5, 2022.

Week 22, 2022

#	Company	Who bought	Shares	Value	Source
1	IOVA IOVANCE BIOTHERAPEUTICS, INC.	2 officers/directors Cluster buy Merrill A. Mcpeak, Wayne P. Rothbaum	1,020,000	$6.7M	SEC filings
2	NEXI NexImmune, Inc.	2 officers/directors Cluster buy Grant Verstandig, Sol J. Barer	233,124	$524K	SEC filings
3	KFS KINGSWAY FINANCIAL SERVICES INC	2 officers/directors Cluster buy Charles L. Frischer, Joseph Stilwell	47,000	$254K	SEC filings
4	AVDL AVADEL PHARMACEUTICALS PLC	2 officers/directors Cluster buy Thomas S. Mchugh, Gregory J. Divis	100,000	$209K	SEC filings
5	EVLO Evelo Biosciences, Inc.	2 separate filers Flagship Ventures Fund IV General Partner LLC, Lord Ara Darzi	27,739,724	$40.5M	SEC filings
6	GBTG Global Business Travel Group, Inc.	10% Owner Apollo Principal Holdings III GP Ltd	2,000,000	$20.0M	SEC filings
7	CGEM Cullinan Oncology, Inc.	10% Owner BVF PARTNERS L P/IL	751,396	$8.3M	SEC filings
8	NSIT INSIGHT ENTERPRISES INC	Director ValueAct Holdings, L.P.	80,000	$7.9M	SEC filings
9	CABO Cable One, Inc.	Director Thomas Sinnickson Gayner	5,000	$6.5M	SEC filings
10	NRXP NRX Pharmaceuticals, Inc.	Chief Scientist Jonathan C. Javitt	100,000	$5.8M	SEC filings

Source: SEC Form 4 filings, aggregated per company over the week. Open-market purchases of $100K or more only; grants, awards, option exercises and likely IPO or offering allocations are excluded. Cluster buys (two or more officers or directors buying) rank first, then by dollar value.

Not investment advice. This page reports public SEC data and is not a recommendation to buy or sell any security.